The largest database of trusted experimental protocols

Interferon gamma ifn γ

Manufactured by Thermo Fisher Scientific
Sourced in United States, United Kingdom

Interferon-gamma (IFN-γ) is a cytokine secreted by various immune cells, primarily T-cells and natural killer cells. It plays a crucial role in the activation and regulation of the immune system.

Automatically generated - may contain errors

28 protocols using interferon gamma ifn γ

1

Murine Macrophage Differentiation and Activation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Murine bone marrow-derived macrophages (BMDMs) were extracted from 8-week-old male C57BL/6 mice according to previously reported protocol [31 (link)].Cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM) supplemented 10% of fetal bovine serum (FBS), 1% penicillin/streptomycin (P/S) and 20 ng/ml recombination murine Macrophage Colony Stimulating Factor (M-CSF, PeproTech). After 7 days, the mature macrophages were obtained and the successful extraction of cells was confirmed by flow cytometry (FCM). Proinflammatory BMDMs activation was achieved by stimulating mature BMDMs with 100 ng/ml lipopolysaccharide (LPS, Sigma) and 20 ng/ml Interferon-Gamma (IFN-γ, PeproTech) for 24 h. Human umbilical vein endothelial cells (HUVECs, ATCC) were cultured using Endothelial Cell Medium (ECM, Sciencell). Mouse atrial myocyte (HL-1, ATCC) were cultured in Dulbecco’s modified Eagle’s medium (DMEM) supplemented 10% of FBS and 1% P/S. Cells were all cultured in a humidified cell culture incubator (ThermoFisher Scientific) at 37 ℃ with 5% carbon dioxide (CO2).
+ Open protocol
+ Expand
2

Effects of Stress Factors on LHQW Degradation

Check if the same lab product or an alternative is used in the 5 most similar protocols
LHQW was provided by Shijiazhuang Yiling Pharmaceutical Co., Ltd (Shijiazhuang, China); the lot number and liquid chromatography profile is shown in Table 1 and Supplementary Figure 1. Among the samples, S40a, S40b and S40c were self-made by treating S40 under a high temperature (60 °C), high humidity (95%) and light intensity (4500 l×) for 20 days (Chinese Pharmacopoeia Commission 2020). Lipopolysaccharide (LPS) was purchased from Sigma-Aldrich (Lot. 113M4068V, St. Louis, MO). Interferon-gamma (IFN-γ) was purchased from PeproTech (Lot. 061398, Rocky Hill). Dexamethasone (DXMS) was purchased from National Institutes for Food and Drug Control (Lot. 10029-201506, Beijing, China). The IL-6 assay kit was purchased from Beijing DAKEWE Biotechnology Co., LTD (Lot. 12-2060-096, Beijing, China). Dulbecco's modified Eagle medium (DMEM) was purchased from HyClone Company (Lot. SH3002201, Logan, UT). Foetal bovine serum, trypsin and penicillin-streptomycin solution were purchased from Gibco (Lot. 10082139, Lot. 25200056, Lot. 15070063, Grand Island, NY). Cell Counting Kit-8 (CCK-8) was purchased from Dojindo Laboratories (Lot. GD619, Kumamoto, Japan). Phosphate-buffered saline (PBS) was purchased from Beijing Solarbio Science & Technology Co., Ltd. (Lot. P1020-500, Beijing, China). Dimethyl sulfoxide (DMSO) was purchased from AMRESCO (Lot. 3304C252, Lardner, PA).
+ Open protocol
+ Expand
3

Monocyte Polarization: M1 and M2 Induction

Check if the same lab product or an alternative is used in the 5 most similar protocols
For M1 polarization, CD14+ monocytes were cultured in 45% RPMI-1640 medium (HyClone), 45% low-glucose DMEM (HyClone) and 10% FBS (Biowest) with inducer medium 1 (M1), which contained granulocyte-macrophage colony-stimulating factor (GM-CSF) (50 ng/mL) (Miltenyi Biotec), for 96 h. Then, the medium was removed, and lipopolysaccharides (LPS) (100 ng/mL) (Miltenyi Biotec) and interferon gamma (IFNγ) (50 ng/mL) (Peprotech) were added, and the cells were incubated for 48 h. To induce M2 polarization, CD14+ monocytes were cultured in 45% RPMI-1640 medium (HyClone), 45% low-glucose DMEM (HyClone) and 10% FBS (Biowest) with inducer medium 2 (M2), which contained M-CSF (50 ng/mL) (Peprotech), for 96 h. Then, the medium was removed, and new medium consisting of interleukin-4 (IL-4) (Peprotech) (50 ng/mL) and interleukin 13 (IL-13) (40 ng/mL) (Peprotech) was added, and the cells were incubated for 48 h. CD14+ monocytes without cytokines were cultured as a negative control, absence of inducer medium (M0).
+ Open protocol
+ Expand
4

HDAC 1-3 Silencing in RAW 264.7 Macrophages

Check if the same lab product or an alternative is used in the 5 most similar protocols
In order to downregulate the expression of HDACs 1, 2 and 3, cells were subjected to HDAC 1–3 selective siRNAs as follows. One day prior to transfection, RAW 264.7 macrophages were seeded at 20,000 cells/cm2 to obtain identical cell density at the start of the experiment. siRNA transfection experiments were performed in a 12-well plate upon complexing 50 nM siRNA with 3.5 μl Lipofectamine® 2000 (LF2K, Life technologies) according to the manufacturer’s protocol. After 24 h RAW 264.7 macrophages were washed twice with ice-cold PBS and harvested for RNA isolation or Western blotting. Where indicated, cells were stimulated with 10 ng/ml lipopolysaccharide (LPS, Escherichia coli, serotype 0111:B4; Sigma–Aldrich, Zwijndrecht, The Netherlands) and 10 ng/ml interferon gamma (IFNγ, #315-05; PeproTech, Hamburg, Germany) for the last 4 h of the experiment. The following siRNAs were used: mouse HDAC 1 (s119559), HDAC 2 (s67417), HDAC 3 (s67421) and Negative Control siRNA (4390843). All siRNAs used were Silencer® Select Pre-Designed & Validated siRNAs purchased from Ambion® by Life Technologies.
+ Open protocol
+ Expand
5

Macrophage Differentiation from U937 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
U937 cells were induced into macrophages according to reference [20 (link)]. U937 cells were collected by centrifugation and inoculated in a 6-well plate at 8 × 105 cells/well. U937-M0 (inactive type) was obtained using phorbol myristate acetate (PMA, 5 ng/mL, Biyuntian Company). PMA was added in the dark and the cells cultured for 48 h at 37 °C with 5% CO2. The medium containing PMA was then replaced, and 20 ng/mL interferon-gamma (IFN-γ, PeproTech, Rocky Hill, NJ, USA) and 100 ng/mL lipopolysaccharide (LPS, Sigma, St. Louis, MO, USA) were added for 24 h to induce and achieve U937-M1 cells (classic activated type).
+ Open protocol
+ Expand
6

Macrophage Polarization Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
The isolated monocytes were cultured for 5 days in RPMI 1640, supplemented with 10% FBS and 25 ng/ml of Recombinant Macrophage Colony-Stimulating Factor (M-CSF, PeproTech, Rocky Hill, USA) to generate M0 macrophages. After 5 days, macrophages were polarized in vitro toward M1 or M2 phenotypes. For M1-like polarization, macrophages were cultured in RPMI-1640 medium supplemented with 100 ng/ml lipopolysaccharides (LPS from E. coli; Sigma-Aldrich) and 50 ng/ml interferon-gamma (IFN-γ; PeproTech) and incubated for 18 h. Meanwhile, for M2-like polarization macrophages were cultured in a complete RPMI-1640 medium supplemented with 20 ng/ml interleukin-4 (IL-4; PeproTech), for 18 h.
The culture medium of M2 macrophages was supplemented with tumor necrosis factor-alpha (TNFα; 20 ng/ml; PeproTech) and Transforming Growth Factor-beta (TGFβ; 10 ng/ml; PeproTech) for 18 h as previously reported [18 (link)].
+ Open protocol
+ Expand
7

Investigating Cell Inflammatory Response Modulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells or PCLS were pre-treated with C646 at 1, 5, 10, 15, 20, 25 or 30 μM (for PCLS the 30 μM concentration was not included due to decreased viability), or with the HDACi SAHA at 0.41 μM for 16 hrs. Inhibitor stocks were prepared in dimethylformamide (DMF) and were further diluted in DMEM culture medium. Vehicle treatment constituted of pre-treatment with 0.3% DMF for the cells (corresponding to the same final DMF% as for 30 μM C646), or with 0.2% DMF for PCLS (corresponding to the same final DMF% as for 20 μM C646), for 16 hrs. Subsequently, cells were stimulated with 10 ng/mL lipopolysaccharide (LPS, Escherichia coli, serotype 0111:B4; Sigma-Aldrich) and 10 ng/mL interferon gamma (IFNγ, cat.#315-05; PeproTech, Hamburg, Germany) for 4 hrs, in continued presence of the inhibitors.
+ Open protocol
+ Expand
8

Immune-Inflammatory Cell Interaction Study

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human umbilical vein endothelial cells (HUVECs), primary human dermal fibroblasts (HDFs), and related media for cell culture, including endothelial growth medium, were purchased from Lonza (Walkersville, MD, USA). HDFs were cultured in Dulbecco’s modified Eagle’s medium (DMEM/F12) (Corning, NY, USA) supplemented with 10% fetal bovine serum (FBS) (FB Essence, VWR, PA, USA) and 1% penicillin/streptomycin (HyClone, IL, USA) and incubated at 37 °C and 5% CO2 throughout the experiment. THP-1 human monocytic cells were obtained from American Type Culture Collection (ATCC) (Manassas, VA, USA). THP-1 cells were maintained in Roswell Park Memorial Institute (RPMI-1640) medium (Corning) supplemented with 10% fetal bovine essence (FBE; VWR, USA) and 0.05 mM 2-mercaptoethanol (Sigma-Aldrich, Milwaukee, WI, USA). Phosphate-buffered saline (PBS) and [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) colorimetric assay were purchased from Promega (Madison, WI, USA), while growth factor reduced matrigel BD was from Corning. The cell staining solution was obtained from Cell Biolabs (San Diego, CA, USA) and Culture-Insert was purchased from IbiTreat (Martinsried, Germany). 12-myristate 13-acetate (PMA) and LPS from Escherichia Coli were purchased from Sigma. Interferon-gamma (IFN-γ) was purchased from PeproTech (Rocky Hill, NJ, USA).
+ Open protocol
+ Expand
9

Inflammatory Cytokine and Chemokine Measurement

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following reagents were used to treat cells: lipopolysaccharide (LPS) from E. coli strain O127:B8 (100 ng/mL; Sigma Aldrich), Pam3CSK4 (100 ng/mL; Invivogen), R-FSL-1 (250 ng/mL; EMC Microcollection Gmbh), interferon gamma (IFNγ; 10 ng/mL; Peprotech) and adenosine triphosphate (ATP; 5 mM; Sigma Aldrich). Concentrations of interleukin-1beta (IL-1β), interleukin-6 (IL-6), interleukin-10 (IL-10) and tumor necrosis factor (TNF) in cell supernatants were measured using the Human Inflammatory Cytokine Cytometric Bead Array Kit (BD Biosciences). Concentrations of chemokines in cell supernatants were measured using the LEGENDplex™ Human Proinflammatory Chemokine Panel 1 (Biolegend). Readings were made on an Attune™ Nxt Flow Cytometer.
+ Open protocol
+ Expand
10

Murine Glioma and Macrophage Proliferation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Murine GL261 glioma cells and the RAW 264.7 macrophage cell line were obtained from the Developmental Therapeutics Program (DTP), Division of Cancer Treatment and Diagnosis (DCTD) Tumor Repository (National Institutes of Health (NIH), Frederick, MD) and American Type Culture Collection (ATCC), Manassas, Virginia, respectively, and cultured in Dulbecco’s modified Eagle’s medium (Cellgro) with 10% FBS (Cellgro) and antibiotics (50 U/ml penicillin and 50 μg/ml streptomycin) in a humidified atmosphere of CO2/air (5%/95%) at 37°C.
For macrophage polarization, RAW 264.7 cells were cultured in complete medium and stimulated for 24 hours with 1 ng/ml lipopolysaccharides from Escherichia coli 055:B5 (Sigma, St. Louis, Missouri) and 10 IU/ml Interferon gamma (IFN-γ) (Peprotech, Rocky Hill, New Jersey) for M1 or 20 ng/ml Interleukin 4 (IL-4) (R&D Systems, Minneapolis, Minnesota) for M2 activation.
GL261 and RAW 264.7 cell lines were treated with AP20187 with different concentrations (0.01, 0.1, 1, and 10 nM) or vehicle for 24 or 48 hours, and cell proliferation was measured using CyQUANT Direct Cell Proliferation Assay Kit (Life Technologies, Grand Island, New York) according the manufacturer’s protocol.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!